Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserved ejection fraction, according to COPD status, in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin P. Lefkowitz, Michael R. Zile, Dirk J. Van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo P. Maggioni, Michele Senni, Brian L. Claggett, Scott D. Solomon, John J. V. McMurray
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2021-12-01
Saila:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Gaiak:	chronic obstructive pulmonary disease heart failure with preserved ejection fraction right ventricle sacubitril/valsartan
Sarrera elektronikoa:	https://www.ahajournals.org/doi/10.1161/JAHA.121.021494
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!